Paper28632001
Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.
Langleben D and 1 other. Pulm Circ, 2017. Cited by 9 papers, by iCite.
Cite this record
ConductScience Library. Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis. Papers, record 28632001. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28632001
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Vasodilator responsiveness in idiopathic pulmonary arterial hypertension: identifying a distinct phenotype with distinct physiology and distinct prognosis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7049203 | Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment. | Br Heart J | 1982 | https://conductscience.org/library/papers/7049203 | PubMed |
| 2 | 434677 | Primary pulmonary hypertension treated with oral phentolamine. | Ann Intern Med | 1979 | https://conductscience.org/library/papers/434677 | PubMed |
| 3 | 22679007 | Modern age pathology of pulmonary arterial hypertension. | Am J Respir Crit Care Med | 2012 | https://conductscience.org/library/papers/22679007 | PubMed |
| 4 | 7294549 | Adverse hemodynamic effects of phentolamine in primary pulmonary hypertension. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7294549 | PubMed |
| 5 | 12581683 | Assessment of the vasodilator response in primary pulmonary hypertension. Comparing prostacyclin and iloprost administered by either infusion or inhalation. | Eur Heart J | 2003 | https://conductscience.org/library/papers/12581683 | PubMed |
| 6 | 7070457 | Deleterious effects of hydralazine in patients with pulmonary hypertension. | N Engl J Med | 1982 | https://conductscience.org/library/papers/7070457 | PubMed |
| 7 | 13692506 | Primary pulmonary hypertension. Effect of unilateral pulmonary artery occlusion and infusion of acetylcholine. | Am J Cardiol | 1961 | https://conductscience.org/library/papers/13692506 | PubMed |
| 8 | 16505173 | Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy. | Circulation | 2006 | https://conductscience.org/library/papers/16505173 | PubMed |
| 9 | 7350435 | Oral hydralazine therapy for primary pulmonary hypertension. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7350435 | PubMed |
| 10 | 7073916 | Failure of nifedipine treatment in primary pulmonary hypertension. | Br Heart J | 1982 | https://conductscience.org/library/papers/7073916 | PubMed |
| 11 | 11315930 | Pulmonary capillary endothelial dysfunction in early systemic sclerosis. | Arthritis Rheum | 2001 | https://conductscience.org/library/papers/11315930 | PubMed |
| 12 | 7295436 | Hazards of diazoxide in pulmonary hypertension. | Br Heart J | 1981 | https://conductscience.org/library/papers/7295436 | PubMed |
| 13 | 18383374 | Pulmonary capillary endothelial metabolic dysfunction: severity in pulmonary arterial hypertension related to connective tissue disease versus idiopathic pulmonary arterial hypertension. | Arthritis Rheum | 2008 | https://conductscience.org/library/papers/18383374 | PubMed |
| 14 | 24355641 | Definitions and diagnosis of pulmonary hypertension. | J Am Coll Cardiol | 2013 | https://conductscience.org/library/papers/24355641 | PubMed |
| 15 | 3740659 | The case for treatment of selected patients with primary pulmonary hypertension. | Am Rev Respir Dis | 1986 | https://conductscience.org/library/papers/3740659 | PubMed |
| 17 | 15939821 | Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. | Circulation | 2005 | https://conductscience.org/library/papers/15939821 | PubMed |
| 18 | 12972548 | Lipid Raft targeting of the TC10 amino terminal domain is responsible for disruption of adipocyte cortical actin. | Mol Biol Cell | 2003 | https://conductscience.org/library/papers/12972548 | PubMed |
| 19 | 21493097 | Unrecognized glucose intolerance is common in pulmonary arterial hypertension. | J Heart Lung Transplant | 2011 | https://conductscience.org/library/papers/21493097 | PubMed |
| 20 | 6336605 | Captopril in primary pulmonary hypertension. | Circulation | 1983 | https://conductscience.org/library/papers/6336605 | PubMed |
| 21 | 7077805 | Adverse effect of hydralazine in patients with primary pulmonary hypertension. | JAMA | 1982 | https://conductscience.org/library/papers/7077805 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42254880 | Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension. | Pulm Circ | 2026 | https://conductscience.org/library/papers/42254880 | PubMed |
| 42145101 | Variation in SNX29 and Acute Vasodilator Response in Pulmonary Arterial Hypertension. | Circ Res | 2026 | https://conductscience.org/library/papers/42145101 | PubMed |
| 40432822 | Phenotyping vasodilator responsiveness in idiopathic pulmonary arterial hypertension: any role for the cardiopulmonary exercise test? | ERJ Open Res | 2025 | https://conductscience.org/library/papers/40432822 | PubMed |
| 33670032 | mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33670032 | PubMed |
| 32149144 | Electrical Stimulation-Guided Approach to Pulmonary Artery Catheter Ablation in Patients with Idiopathic Pulmonary Arterial Hypertension: A Pilot Feasibility Study with a 12-Month Follow-Up. | Biomed Res Int | 2020 | https://conductscience.org/library/papers/32149144 | PubMed |
Genes13
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28632001
GET https://conductscience.org/api/papers/v1/28632001/references?page=2